Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Taxotere combination therapy approved in E.U. for treatment of advanced breast cancer

Sep. 5, 2000

SuperGen updates progress of phase III rubitecan trials

Sep. 4, 2000

Arimidex approved by FDA as first-line therapy of breast cancer

Sep. 4, 2000

Cytogen and Northwest Biotherapeutics execute PSMA sublicense agreement

Sep. 4, 2000

Study results for Targretin in NSCLC support phase III program

Sep. 4, 2000

Vascular damaging agents reported by Angiogene

Sep. 1, 2000

RXR-selective ligands offer approach to tamoxifen-resistant tumors

Sep. 1, 2000

Novogen's lead anticancer compound continues to advance in clinical trials

Sep. 1, 2000

Cancer gene therapy with fusion molecule induces potent, selective apoptosis

Sep. 1, 2000

Aminobisphosphonates activate T-cells against multiple myeloma

Sep. 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...